Synthomer PLC
LSE:SYNT

Watchlist Manager
Synthomer PLC Logo
Synthomer PLC
LSE:SYNT
Watchlist
Price: 59 GBX -4.99% Market Closed
Market Cap: 96.5m GBX

Synthomer PLC
Investor Relations

Synthomer Plc engages in the development, marketing, and sale of polymer products derived from petrochemical monomers. The company is headquartered in Harlow, Essex and currently employs 4,632 full-time employees. The firm's Performance Elastomers segment is focused on healthcare, paper, carpet and foam markets through its water-based Nitrile Butadiene Rubber latex (NBR) and Styrene Butadiene Rubber latex (SBR) products. Its Functional Solutions segment is focused on coatings, construction, adhesives and technical textiles markets through its water-based acrylic and vinylic based dispersions products. Its Industrial Specialities segment is focused on specialty chemical additives and non-water-based chemistry for a range of applications from polymer additives and laminates and films to emerging materials and technologies. Its Acrylate Monomers is focused on the production of acrylate monomers, which are sold to external customers in European markets as well as its European Functional Solutions dispersions business. The company also operates Adhesive Technologies division.

Show more
Loading
SYNT
FTSE All Share Index
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q4 2021
Call Date
Mar 3, 2022
AI Summary
Q4 2021

Record Results: Synthomer reported a record year in 2021, with sales up 47% to £2.3 billion and EBITDA doubling to £522 million, led by exceptional demand in Performance Elastomers.

NBR Normalization: NBR margins and volumes, which spiked during the pandemic, have now returned to normal levels, with destocking expected to continue into the first half of 2022.

Strategic Acquisitions: The Eastman Adhesive Resins (Adhesive Technologies) and OMNOVA acquisitions were highlighted as transformational, enhancing growth platforms and geographic reach.

Strong Cash Flow & Balance Sheet: Free cash flow more than doubled to £300 million, helping reduce net debt to £114.2 million and leverage to 0.3x EBITDA at year-end, positioning the company well for further investments.

Capital Allocation & Outlook: CapEx is guided to £130 million in 2022, focused on maintaining flexibility and supporting growth, while leverage is expected to rise temporarily to 2.5x post-acquisition and then return to target range (1–2x) within 12–24 months.

Outlook: Management expects a gradual normalization in NBR and continued growth across other divisions, with early signs of margin stabilization and an encouraging start to 2022, especially in margins.

Key Financials
Revenue
£2.3 billion
EBITDA
£522 million
Net Debt
£114.2 million
Leverage
0.3x EBITDA
Free Cash Flow
£300 million
EPS
£0.752
Tax Rate
22.5%
CapEx
£130 million (2022 guidance)
Dividend
£0.213 per share (final); £100 million total payment in July 2022
Defined Benefit Pension Liabilities
£122 million
Provision for European Commission Investigation
£57.2 million
Earnings Call Recording
Other Earnings Calls

Management

Mr. Michael Willome lic. oec. HSG
CEO & Executive Director
No Bio Available
Ms. Lily Liu
CFO & Director
No Bio Available
Mr. Faisal Tabbah
Vice President of Investor Relations
No Bio Available
Mr. Anant Prakash
Chief Counsel & Company Secretary
No Bio Available
Ms. Alice L. M. Heezen-Dokianos
Chief Human Resources Officer
No Bio Available
Mr. Rob Tupker M.B.A., M.Sc.
President of Health, Protection, Performance Materials & Asia
No Bio Available
Ms. Ana Perroni Laloe
President of Coatings & Construction Solutions and EMEA
No Bio Available
Mr. Jan Chalmovsky
President of Strategy and M&A
No Bio Available
Mr. Stephan Lynen
President of Adhesive Solutions
No Bio Available

Contacts

Address
ESSEX
Harlow
Central Road
Contacts
+441279436211.0
www.synthomer.com